Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma : Melanoma Research

Journal Logo

Short communication

Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma

Gargiulo, Luigia,b; Ibba, Lucianoa,b; Valenti, Marioa,b; Costanzo, Antonioa,b; Narcisi, Alessandrab

Author Information
Melanoma Research ():CMR.0000000000000875, December 27, 2022. | DOI: 10.1097/CMR.0000000000000875

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid